Stem cell transplants are commonly recommended for newly diagnosed patients with symptomatic multiple myeloma. The main purpose is to replace cancerous bone marrow cells with healthy stem cells after high-dose chemotherapy has destroyed the diseased cells.
There are two main types of transplants
• Autologous (using Show Full Answer
Stem cell transplants are commonly recommended for newly diagnosed patients with symptomatic multiple myeloma. The main purpose is to replace cancerous bone marrow cells with healthy stem cells after high-dose chemotherapy has destroyed the diseased cells.
There are two main types of transplants:
• Autologous (using patient's own cells) - This is the most common type for myeloma patients
• Allogeneic (using donor cells) - Not considered standard treatment due to higher risk of complications The transplant process typically follows these phases:
1. Induction therapy (initial treatment to control myeloma)
2. Collection of stem cells (usually from blood rather than bone marrow)
3. High-dose chemotherapy
4. Transplantation of stem cells
5. Consolidation therapy (additional rounds of treatment)
While autologous transplants cannot cure myeloma, they can significantly improve outcomes for eligible patients. The specific eligibility criteria should be discussed with your healthcare team, as factors like overall health status and response to initial therapy will be considered.
September 8, 2025
Join
Your Privacy Choices
